LIMK1 and disease arising from reactivation of latent virus: Brief treatment of resting T cells with okadaic acid, a non-specific LIMK activator and phosphatase inhibitor, triggered dramatic LIMK activation and actin polymerization, which led to a significant increase in HIV-1 latent infection.